Literature DB >> 30032182

The Role of Molecular Diagnostics in the Management of Indeterminate Thyroid Nodules.

Joanna Klubo-Gwiezdzinska1, Leonard Wartofsky2.   

Abstract

Mesh：

Year:  2018        PMID： 30032182      PMCID： PMC6456919          DOI： 10.1210/jc.2018-01081

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  23 in total

1.  Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology.

Authors:  Lawrence Lee; Jacques How; Roger J Tabah; Elliot J Mitmaker
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

2.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

Authors:  Erik K Alexander; Giulia C Kennedy; Zubair W Baloch; Edmund S Cibas; Darya Chudova; James Diggans; Lyssa Friedman; Richard T Kloos; Virginia A LiVolsi; Susan J Mandel; Stephen S Raab; Juan Rosai; David L Steward; P Sean Walsh; Jonathan I Wilde; Martha A Zeiger; Richard B Lanman; Bryan R Haugen
Journal:  N Engl J Med       Date:  2012-06-25       Impact factor: 91.245

Review 3.  ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pract       Date:  2017-05-23       Impact factor: 3.443

4.  Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology.

Authors:  Pablo Valderrabano; Laila Khazai; Marino E Leon; Zachary J Thompson; Zhenjun Ma; Christine H Chung; Julie E Hallanger-Johnson; Kristen J Otto; Kara D Rogers; Barbara A Centeno; Bryan McIver
Journal:  Endocr Relat Cancer       Date:  2017-01-19       Impact factor: 5.678

5.  Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.

Authors:  Emmanuel Labourier; Alexander Shifrin; Anne E Busseniers; Mark A Lupo; Monique L Manganelli; Bernard Andruss; Dennis Wylie; Sylvie Beaudenon-Huibregtse
Journal:  J Clin Endocrinol Metab       Date:  2015-05-12       Impact factor: 5.958

6.  Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules.

Authors:  Jennifer L Marti; Vaidehi Avadhani; Luke A Donatelli; Sayani Niyogi; Beverly Wang; Richard J Wong; Ashok R Shaha; Ronald A Ghossein; Oscar Lin; Luc G T Morris; Allen S Ho
Journal:  Ann Surg Oncol       Date:  2015-04-11       Impact factor: 5.344

7.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

8.  Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

Authors:  Yuri E Nikiforov; David L Steward; Toni M Robinson-Smith; Bryan R Haugen; Joshua P Klopper; Zhaowen Zhu; James A Fagin; Mercedes Falciglia; Katherine Weber; Marina N Nikiforova
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958

9.  Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.

Authors:  Marina N Nikiforova; Stephanie Mercurio; Abigail I Wald; Michelle Barbi de Moura; Keith Callenberg; Lucas Santana-Santos; William E Gooding; Linwah Yip; Robert L Ferris; Yuri E Nikiforov
Journal:  Cancer       Date:  2018-01-18       Impact factor: 6.860

10.  Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.

Authors:  Marina N Nikiforova; Abigail I Wald; Somak Roy; Mary Beth Durso; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958
View more
  7 in total

1.  The Hypothalamic Pituitary Thyroid Axis and Sleep.

Authors:  Skand Shekhar; Janet E Hall; Joanna Klubo-Gwiezdzinska
Journal:  Curr Opin Endocr Metab Res       Date:  2020-10-24

2.  Integrative metabolomic characterization identifies plasma metabolomic signature in the diagnosis of papillary thyroid cancer.

Authors:  Shuang Yu; Changan Liu; Yingtong Hou; Jie Li; Zhuming Guo; Xinwen Chen; Luyao Zhang; Sui Peng; Shubin Hong; Lixia Xu; Xiaoxing Li; Rengyun Liu; Shuwei Chen; Bin Li; Zongpeng Weng; Yanbing Li; Weiming Lv; Jun Yu; Haipeng Xiao
Journal:  Oncogene       Date:  2022-03-12       Impact factor: 9.867

3.  A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.

Authors:  Cristiane J Gomes-Lima; Sungyoung Auh; Shilpa Thakur; Marina Zemskova; Craig Cochran; Roxanne Merkel; Armando C Filie; Mark Raffeld; Snehal B Patel; Liqiang Xi; Leonard Wartofsky; Kenneth D Burman; Joanna Klubo-Gwiezdzinska
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-18       Impact factor: 5.555

Review 4.  The Role of Lithium in Management of Endocrine Tumors-A Comprehensive Review.

Authors:  Shilpa Thakur; Andrew Tobey; Joanna Klubo-Gwiezdzinska
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

Review 5.  The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function-A Comprehensive Review.

Authors:  Sonam Kumari; Ruth Adewale; Joanna Klubo-Gwiezdzinska
Journal:  Cells       Date:  2020-06-27       Impact factor: 6.600

Review 6.  Molecular-Driven Therapy in Advanced Thyroid Cancer.

Authors:  Kevin C Miller; Ashish V Chintakuntlawar
Journal:  Curr Treat Options Oncol       Date:  2021-02-10

7.  Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).

Authors:  Shilpa Thakur; Andrew Tobey; Brianna Daley; Sungyoung Auh; Mary Walter; Dhaval Patel; Naris Nilubol; Electron Kebebew; Aneeta Patel; Kirk Jensen; Vasyl Vasko; Joanna Klubo-Gwiezdzinska
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.